The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX is tipped to start its last day of trade for the week fairly flat, or just marginally in front.

The S&P 500 and Nasdaq dropped overnight, hindered by a slip in Tesla and Netflix after its quarterly results were released.

Tesla tumbled nearly 10 per cent as CEO Elon Musk hinted at future price cuts to electric vehicles. Taiwan Semiconductor Manufacturing Company – or TSMC – followed suit – losing five per cent – after the chipmaker’s quarterly revenue was down 13.7 per cent.

Streaming service Netflix was also down, shedding 8.4 per cent after falling short of its quarterly revenue targets, despite cracking down on password sharing.

The Dow Jones, however, rallied for a ninth straight trading session – its longest upwards run in several years. Pharmaceutical company Johnson & Johnson gained more than 6 per cent as it exceeded earnings predictions with MedTech sales and raised its full-year forecasts.

Back home and the Aussie dollar is buying 68 US cents, and 61 Euro cents.

Iron Ore is up 0.7 per cent to $115.15 a tonne, gold is down nearly half a per cent at 1969.62, crude oil is up 0.3 per cent at $79.70 a barrel and natural gas is up 1.15 per cent to $2.63.

More From The Market Online
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…